Sweden · Delayed Price · Currency is SEK Zinzino AB Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw over 20% revenue growth and record gross margins, driven by organic expansion and successful acquisitions. Central Europe and North America led growth, with integration of It Works! and Sanki progressing well. Management expects continued strong performance.
Fiscal Year 2025
-
Q4 2025 saw 45% growth, driven by strong organic and acquisition-fueled expansion, especially in Central Europe. Gross margin improved, and management targets above 20% annual growth and 11%+ EBITDA margin, with integration of major acquisitions underway.
-
Q3 2025 saw robust growth and margin improvement, with Central Europe and North America leading performance. A new gut health test launch and successful acquisitions boosted results, while regulatory compliance remains a focus.
-
Q2 saw 57% growth (47% organic), strong cash flow, and robust performance across most regions, driven by tech investments, product innovation, and M&A. Management is confident in achieving a 10% margin for the year and maintaining profitable growth.
-
Q1 saw 59% year-over-year revenue growth, driven by organic expansion, acquisitions, and strong performance in Central Europe, North America, and Asia-Pacific. Subscription revenue remains robust, and new market entries and product launches are expected to fuel continued growth.